BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3105913)

  • 21. [Randomized double-blind study comparing tissue-type plasminogen activator with placebo in acute myocardial infarct].
    Bleifeld W; Verstraete M; Brower RW; Collen D; Dunning AJ; Lubsen J; Michel PL; Schofer J; Vanhaecke J; Van de Werf F
    Klin Wochenschr; 1988; 66 Suppl 12():86-92. PubMed ID: 3126349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety of acute calcium antagonist withdrawal: studies in patients with unstable angina withdrawn from nifedipine.
    Gottlieb SO; Gerstenblith G
    Am J Cardiol; 1985 May; 55(12):27E-30E. PubMed ID: 3873866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Variables predictive of successful medical therapy in patients with unstable angina: selection by multivariate analysis from clinical, electrocardiographic, and angiographic evaluations.
    Ouyang P; Brinker JA; Mellits ED; Weisfeldt ML; Gerstenblith G
    Circulation; 1984 Sep; 70(3):367-76. PubMed ID: 6378422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aspirin, heparin, or both to treat acute unstable angina.
    Théroux P; Ouimet H; McCans J; Latour JG; Joly P; Lévy G; Pelletier E; Juneau M; Stasiak J; deGuise P
    N Engl J Med; 1988 Oct; 319(17):1105-11. PubMed ID: 3050522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemorrhagic events during therapy with recombinant tissue plasminogen activator, heparin, and aspirin for unstable angina (Thrombolysis in Myocardial Ischemia, phase IIIB trial).
    Bovill EG; Tracy RP; Knatterud GL; Stone PH; Nasmith J; Gore JM; Thompson BW; Tofler GH; Kleiman NS; Cannon C; Braunwald E
    Am J Cardiol; 1997 Feb; 79(4):391-6. PubMed ID: 9052337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined use of nitroglycerin and N-acetylcysteine in the management of unstable angina pectoris.
    Horowitz JD; Henry CA; Syrjanen ML; Louis WJ; Fish RD; Smith TW; Antman EM
    Circulation; 1988 Apr; 77(4):787-94. PubMed ID: 3127076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coronary thrombolysis with recombinant tissue-type plasminogen activator: patency rate and regional wall motion after 3 months.
    Jang IK; Vanhaecke J; De Geest H; Verstraete M; Collen D; Van de Werf F
    J Am Coll Cardiol; 1986 Dec; 8(6):1455-60. PubMed ID: 3097099
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nifedipine and conventional therapy for unstable angina pectoris: a randomized, double-blind comparison.
    Muller JE; Turi ZG; Pearle DL; Schneider JF; Serfas DH; Morrison J; Stone PH; Rude RE; Rosner B; Sobel BE
    Circulation; 1984 Apr; 69(4):728-39. PubMed ID: 6365349
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of low-dose aspirin and coronary vasodilators in acute unstable angina.
    Vejar M; Hackett D; Brunelli C; Spallarossa P; Ianetti M; Galassi AR; Lipkin D; Caponnetto S; Patrono C; Maseri A
    Circulation; 1990 Jan; 81(1 Suppl):I4-11; discussion I22-3. PubMed ID: 2403867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparative randomized study of the effectiveness of intravenous recombinant tissue-type plasminogen activator and intravenous streptokinase in patients with acute myocardial infarct. Report of the European Cooperative Study Group for Recombinant Tissue-Type Plasminogen Activator].
    Verstraete M; Bory M; Collen D; Erbel R; Lennane RJ; Mathey D; Michels HR; Schartl M; Uebis R; Bernard R
    Klin Wochenschr; 1988; 66 Suppl 12():77-85. PubMed ID: 3126348
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heparin induced increase of t-PA antigen plasma levels in patients with unstable angina: no evidence for clinical benefit of heparinization during the initial phase of treatment.
    Huber K; Resch I; Rosc D; Probst P; Kaindl F; Binder BR
    Thromb Res; 1989 Sep; 55(6):779-84. PubMed ID: 2506671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beneficial effects of high-dose diltiazem in patients with persistent effort angina on beta-blockers and nitrates: a randomized, double-blind, placebo-controlled cross-over study.
    Boden WE; Bough EW; Reichman MJ; Rich VB; Young PM; Korr KS; Shulman RS
    Circulation; 1985 Jun; 71(6):1197-205. PubMed ID: 2859931
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized trial of intraoperative, intracisternal tissue plasminogen activator for the prevention of vasospasm.
    Findlay JM; Kassell NF; Weir BK; Haley EC; Kongable G; Germanson T; Truskowski L; Alves WM; Holness RO; Knuckey NW
    Neurosurgery; 1995 Jul; 37(1):168-76; discussion 177-8. PubMed ID: 8587685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prolonged streptokinase infusion in patients with unstable angina: results of a randomized, placebo-controlled clinical trial.
    Oltrona L; Merlini PA; Spinola A; Ardissino D; Granata D; Lombardo M; Zaini G; Cioffi P; Pezzano A
    Coron Artery Dis; 1996 May; 7(5):377-82. PubMed ID: 8866204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diltiazem, nifedipine, and their combination in patients with stable angina pectoris: effects on angina, exercise tolerance, and the ambulatory electrocardiographic ST segment.
    Frishman W; Charlap S; Kimmel B; Teicher M; Cinnamon J; Allen L; Strom J
    Circulation; 1988 Apr; 77(4):774-86. PubMed ID: 3280158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET).
    Wilcox RG; von der Lippe G; Olsson CG; Jensen G; Skene AM; Hampton JR
    Lancet; 1988 Sep; 2(8610):525-30. PubMed ID: 2900919
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of heparin, aspirin, or alteplase in reduction of myocardial ischaemia in refractory unstable angina.
    Neri Serneri GG; Gensini GF; Poggesi L; Trotta F; Modesti PA; Boddi M; Ieri A; Margheri M; Casolo GC; Bini M
    Lancet; 1990 Mar; 335(8690):615-8. PubMed ID: 1969013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Intravenous infusion of recombinant tissue-type plasminogen activator (rt-PA) and urokinase in acute myocardial infarct: intermediate results of the G.A.U.S. study (German Activator Urokinase Study)].
    Neuhaus KL; Tebbe U; Gottwik M; Weber MA; Feuerer W; Niederer W; Haerer W; Praetorius F; Grosser KD; Huhmann W
    Klin Wochenschr; 1988; 66 Suppl 12():102-8. PubMed ID: 3126339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized trial of intravenous tissue plasminogen activator for acute myocardial infarction with subsequent randomization to elective coronary angioplasty.
    Guerci AD; Gerstenblith G; Brinker JA; Chandra NC; Gottlieb SO; Bahr RD; Weiss JL; Shapiro EP; Flaherty JT; Bush DE
    N Engl J Med; 1987 Dec; 317(26):1613-8. PubMed ID: 2960897
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of nifedipine and metoprolol in the early treatment of unstable angina in the coronary care unit: findings from the Holland Interuniversity Nifedipine/metoprolol Trial (HINT).
    Lubsen J; Tijssen JG
    Am J Cardiol; 1987 Jul; 60(2):18A-25A. PubMed ID: 2887097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.